Logotipo do repositório
 

Publicação:
Biological Properties of Extracts from Byrsonima Species in Microemulsions

dc.contributor.authorLima Neto, José de Sousa [UNESP]
dc.contributor.authorMarena, Gabriel Davi
dc.contributor.authorGirotto, Luiza
dc.contributor.authorMagorpo, Vanessa
dc.contributor.authorRamos, Matheus Aparecido dos Santos [UNESP]
dc.contributor.authorSilva, Patrícia Bento da [UNESP]
dc.contributor.authorChorilli, Marlus [UNESP]
dc.contributor.authorBauab, Tais Maria [UNESP]
dc.contributor.authorResende, Flávia Aparecida
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversidade de Araraquara
dc.contributor.institutionUniversidade de Brasília (UnB)
dc.date.accessioned2023-03-01T20:37:56Z
dc.date.available2023-03-01T20:37:56Z
dc.date.issued2022-06-01
dc.description.abstractThe Byrsonima genus, Malpighiaceae, represents a rich source of phenolic compounds with proven pharmacological properties (antiulcerogenic, antimicrobial, antimutagenic, and antioxidant activities). In this context, the aim of the present study was to identify chemical compounds employing UPLC-PDA-ESI-QTOF-MS/MS and FIA-ESI-IT-MSn and evaluate the antimicrobial activity and toxicogenetic effects of hydroethanolic extracts obtained from B. coccolobifolia Kunth and B. ligustrifolia Mart. incorporated and not incorporated in microemulsions. The former presents grape seed oil and cholesterol at a 5:1 ratio, as an oily phase (10%) (microemulsion 1) and the other, only cholesterol (microemulsion 2). Both extracts and their formulations exhibited greater antifungal potential compared to antibacterial. The formulations, however, were highly cytotoxicity compared to free extracts and exhibited a lower selectivity index. The B. ligustrifolia formulations did not present mutagenic activity and inhibited previously detected extract mutagenicity, while B. coccolobifolia formulations microemulsion 2 induced mutations of the base pair substitution type in Typhimurium strains and oxidative damage in TA102 when assessed by the Ames test. [Figure not available: see fulltext.].en
dc.description.affiliationFaculdade de Ciências Farmacêuticas Universidade Estadual Paulista, São Paulo
dc.description.affiliationDepartamento de Ciências Biológicas e Saúde Universidade de Araraquara, São Paulo
dc.description.affiliationDepartamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, São Paulo
dc.description.affiliationDepartmento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, São Paulo
dc.description.affiliationDepartmento de Genética e Morfologia Laboratório de Nanotecnologia Instituto de Ciências Biológicas Universidade de Brasília, Distrito Federal
dc.description.affiliationUnespFaculdade de Ciências Farmacêuticas Universidade Estadual Paulista, São Paulo
dc.description.affiliationUnespDepartamento de Ciências Biológicas Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, São Paulo
dc.description.affiliationUnespDepartmento de Fármacos e Medicamentos Faculdade de Ciências Farmacêuticas Universidade Estadual Paulista, São Paulo
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdCAPES: CAPES PDSE Processo - 9479-11-2
dc.description.sponsorshipIdCAPES: CAPES Processo -Finance Code 001
dc.description.sponsorshipIdFAPESP: FAPESP Proc nº 2018/01381-1
dc.description.sponsorshipIdFAPESP: FAPESP Proc nº 2019/06818-1
dc.description.sponsorshipIdFAPESP: Regular assistance FAPESP Proc nº 2017/16278-9
dc.format.extent460-465
dc.identifierhttp://dx.doi.org/10.1007/s43450-022-00256-8
dc.identifier.citationRevista Brasileira de Farmacognosia, v. 32, n. 3, p. 460-465, 2022.
dc.identifier.doi10.1007/s43450-022-00256-8
dc.identifier.issn1981-528X
dc.identifier.scopus2-s2.0-85129193293
dc.identifier.urihttp://hdl.handle.net/11449/240906
dc.language.isoeng
dc.relation.ispartofRevista Brasileira de Farmacognosia
dc.sourceScopus
dc.subjectAntimicrobials
dc.subjectBiopharmaceuticals
dc.subjectBiotechnology
dc.subjectCytogenotoxic
dc.subjectMurici
dc.subjectNanotechnology
dc.titleBiological Properties of Extracts from Byrsonima Species in Microemulsionsen
dc.typeArtigopt
dspace.entity.typePublication
relation.isDepartmentOfPublication5004bcab-94af-4939-b980-091ae9d0a19e
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscovery5004bcab-94af-4939-b980-091ae9d0a19e
unesp.author.orcid0000-0002-3933-6391[1]
unesp.author.orcid0000-0002-4573-5743[2]
unesp.author.orcid0000-0002-3818-7099[3]
unesp.author.orcid0000-0002-2609-1989[4]
unesp.author.orcid0000-0003-3359-3298[5]
unesp.author.orcid0000-0001-8335-0708[6]
unesp.author.orcid0000-0002-6698-0545[7]
unesp.author.orcid0000-0002-1929-6003[8]
unesp.author.orcid0000-0002-9432-5919[9]
unesp.departmentCiências Biológicas - FCFpt
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos